Albemarle Corp. vs Twist Bioscience Corp — how do they compare? Albemarle Corp. trades at $131.06 (market cap $15.27B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Albemarle Corp. is the larger of the two by market cap, and Albemarle Corp. pays a 1.27% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| ALB | TWST | |
|---|---|---|
Market Cap | $15.27B | $7.72B |
Sector | Basic Materials | Health |
52-Week High | $215.62 | $124.88 |
52-Week Low | $72.58 | $24.16 |
Enterprise Value | $17.75B | $7.65B |
Dividend Yield | 1.27% | — |
Trailing returns across standard periods
Albemarle is the world's largest lithium producer. Our outlook for robust lithium demand is predicated upon increased demand for electric vehicle batteries. Albemarle produces lithium from its salt brine deposits in Chile and the U.S. and its hard rock joint venture mines in Australia. Albemarle is also a global leader in the production of bromine, used in flame retardants. The company is also a major producer of oil refining catalysts.
Read more on ALB →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →